RaySearch Laboratories AB (publ)

RAY-B · Nasdaq Stockholm · Healthcare

181.00SEK −1.7%last day

Price as of 2 October 2026

The price over the past year, with dividends: −26.7%

Performance

1 month

+2.0%

1 year

−26.7%

3 years, per year

+33.4%

5 years, per year

+25.7%

Largest fall, 3 years

−54.1%

Below the peak now

−49.4%

Volatility, 1 year

49.2%

Return with dividends reinvested.

Key figures

P/E

28.1

P/B

7.6

Dividend yield

2.2%

Return on equity

+27.0%

Net margin

+16.8%

Market value

616 m USD

Quality, value and trend

Where RaySearch Laboratories stands against every Nordic stock today. 100 is best.

Quality80

Profitability and a sound balance sheet over time. Better than 80% of Nordic stocks.

Value18

The price measured against earnings, assets and cash flow. Better than 18% of Nordic stocks.

Trend18

The price development over the past year. Better than 18% of Nordic stocks.

Combined26

Quality, value and trend together. Better than 26% of Nordic stocks.

About RaySearch Laboratories

RaySearch Laboratories AB (publ) is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 460 employees.

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. It offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis